Price T Rowe Associates Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Price T Rowe Associates Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $84,125 - $348,520	-300,449 Reduced 9.11%	2,997,781 $991,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $179,006 - $282,019	-168,874 Reduced 4.87%	3,298,230 $3.83 Million
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $25,182 - $35,774	19,986 Added 0.58%	3,467,104 $5.86 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $19,622 - $30,957	12,188 Added 0.35%	3,447,118 $6.24 Million
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $61,492 - $105,184	-53,941 Reduced 1.55%	3,434,930 $6.39 Million
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $683,978 - $1.25 Million	-569,982 Reduced 14.04%	3,488,871 $4.64 Million
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $256,002 - $552,840	-157,057 Reduced 3.73%	4,058,853 $6.86 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $19,177 - $98,253	26,271 Added 0.63%	4,215,910 $13.2 Million
Q2 2022 Aug 15, 2022	SELL	$2.2 - $4.2 $10.2 Million - $19.5 Million	-4,641,539 Reduced 52.56%	4,189,639 $9.97 Million
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $18.6 Million - $57 Million	6,561,824 Added 289.15%	8,831,178 $35.6 Million
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $16.4 Million - $29.5 Million	1,977,454 Added 677.44%	2,269,354 $18.9 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $2.67 Million - $3.88 Million	291,900 New	291,900 $3.38 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.